Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Douglas Barnas"'
Autor:
Francesca T. Aweeka, Robert W. Coombs, David M. Margolis, David W. Haas, Sarah Palmer, Diane V. Havlir, Zhaohui Su, Sheran S. Patel, Gene D. Morse, Douglas Barnas, John M. Coffin, C. Bradley Hare, John W. Mellors, Lisa M. Frenkel, Amy Krambrink, Valerie F. Boltz, Daniel J. Skiest
Publikováno v:
Clinical Infectious Diseases. 47:421-424
Using standard and ultrasensitive techniques, we detected nonnucleoside reverse-transcriptase inhibitor-associated resistance mutations in 11 (20%) of 54 subjects who discontinued virologically suppressive nonnucleoside reverse-transcriptase inhibito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::325e01173469c62b22f37e70b9abbb3a
https://doi.org/10.1086/589867
https://doi.org/10.1086/589867
Autor:
Dianna Koontz, Douglas Barnas, Christian J. Bixby, Holly Bazmi, John W. Mellors, Joseph G. Jemsek
Background The rapid failure of initial therapy with combinations of nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) that exclude zidovudine has not been fully explained by standard virus population analyses of HIV type-1 (HIV-1) drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6db4ead254b1301a7dc19c37f4ceecef
https://europepmc.org/articles/PMC2902251/
https://europepmc.org/articles/PMC2902251/
Publikováno v:
The Journal of infectious diseases. 194(5)
Prior virologic and biochemical studies have shown phenotypic antagonism between K65R and multiple thymidine-analogue mutations (TAMs) in site-directed mutants tested in vitro. We hypothesized, on the basis of this observed antagonism, that K65R and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f9f2ab527e5ce0b7c2cf069a6d7eea5
https://pubmed.ncbi.nlm.nih.gov/16897664
https://pubmed.ncbi.nlm.nih.gov/16897664